Drug Repurposing: A Potential Therapeutic Strategy for the Treatment of Chikugunya Virus
This study demonstrates that drug repurposing, specifically using the HIV protease inhibitor Indinavir to stabilize and block the Chikungunya virus nsP2 active site via molecular dynamics simulations, offers a promising and cost-effective therapeutic strategy for treating CHIKV infection.